Oric Pharmaceuticals Inc (ORIC)

Dec 18, 2024

Brokerages Set ORIC Pharmaceuticals, Inc. (NASDAQ:ORIC) Price Target at $18.29 - MarketBeat

Dec 18, 2024

Dec 17, 2024

Dominic Piscitelli Sells 8,851 Shares of ORIC Pharmaceuticals, Inc. (NASDAQ:ORIC) Stock - MarketBeat

Dec 17, 2024

Dec 17, 2024

Pratik S. Multani Sells 8,850 Shares of ORIC Pharmaceuticals, Inc. (NASDAQ:ORIC) Stock - MarketBeat

Dec 17, 2024

Dec 17, 2024

ORIC Pharmaceuticals, Inc. (NASDAQ:ORIC) CEO Sells $204,184.80 in Stock - MarketBeat

Dec 17, 2024

Dec 17, 2024

Oric Pharmaceuticals chief medical officer sells $73,293 in stock - Investing.com India

Dec 17, 2024

Dec 17, 2024

Oric Pharmaceuticals chief medical officer sells $73,293 in stock By Investing.com - Investing.com Australia

Dec 17, 2024

Dec 17, 2024

Oric Pharmaceuticals CFO sells $73,297 in stock - Investing.com India

Dec 17, 2024

Dec 17, 2024

Oric Pharmaceuticals CFO sells $73,297 in stock By Investing.com - Investing.com Australia

Dec 17, 2024

Dec 17, 2024

Oric Pharmaceuticals CEO Chacko Jacob sells $204,214 in stock - Investing.com

Dec 17, 2024

Dec 17, 2024

Oric Pharmaceuticals CEO Chacko Jacob sells $204,214 in stock By Investing.com - Investing.com UK

Dec 17, 2024

Dec 16, 2024

ORIC Pharmaceuticals (NASDAQ:ORIC) Shares Gap DownTime to Sell? - MarketBeat

Dec 16, 2024

Dec 16, 2024

(ORIC) Technical Data - Stock Traders Daily

Dec 16, 2024

Dec 14, 2024

Charles Schwab Investment Management Inc. Boosts Stock Position in ORIC Pharmaceuticals, Inc. (NASDAQ:ORIC) - MarketBeat

Dec 14, 2024

Dec 10, 2024

ORIC Pharmaceuticals (STU:4TZ) Operating Margin % : 0.00% (As of Sep. 2024) - GuruFocus.com

Dec 10, 2024

Dec 08, 2024

Fmr LLC Decreases Holdings in ORIC Pharmaceuticals, Inc. (NASDAQ:ORIC) - Defense World

Dec 08, 2024

Dec 08, 2024

ORIC Pharmaceuticals, Inc. (NASDAQ:ORIC) Stock Position Lowered by Fmr LLC - MarketBeat

Dec 08, 2024

Dec 05, 2024

How to Take Advantage of moves in (ORIC) - Stock Traders Daily

Dec 05, 2024

Dec 03, 2024

ArrowMark Colorado Holdings LLC Acquires 80,986 Shares of ORIC Pharmaceuticals, Inc. (NASDAQ:ORIC) - MarketBeat

Dec 03, 2024

Dec 02, 2024

Fred Alger Management LLC Acquires 63,535 Shares of ORIC Pharmaceuticals, Inc. (NASDAQ:ORIC) - MarketBeat

Dec 02, 2024

Nov 28, 2024

Victory Capital Management Inc. Has $1.02 Million Stock Holdings in ORIC Pharmaceuticals, Inc. (NASDAQ:ORIC) - Defense World

Nov 28, 2024

Nov 26, 2024

ORIC Pharmaceuticals, Inc. (NASDAQ:ORIC) Receives $18.29 Consensus Price Target from Brokerages - Defense World

Nov 26, 2024

Nov 25, 2024

ORIC® Pharmaceuticals to Participate in Upcoming Investor Conferences - The Manila Times

Nov 25, 2024

Nov 25, 2024

ORIC Pharmaceuticals to Present at Major Healthcare Conferences in December | ORIC Stock News - StockTitan

Nov 25, 2024

Nov 24, 2024

Long Term Trading Analysis for (ORIC) - Stock Traders Daily

Nov 24, 2024

Nov 22, 2024

ORIC Pharmaceuticals (STU:4TZ) GF Value Rank : 0 (As of Nov. 22, 2024) - GuruFocus.com

Nov 22, 2024

Nov 21, 2024

ORIC Pharmaceuticals (STU:4TZ) Enterprise Value : €327.63 Mil (As of Nov. 21, 2024) - GuruFocus.com

Nov 21, 2024

Nov 20, 2024

ORIC: Working with Two Pharma Giants, Analysts See +100% Upside - MSN

Nov 20, 2024

Nov 20, 2024

C4 Therapeutics Appoints Accomplished Oncology Executive Steve Hoerter to Board of Directors - GlobeNewswire Inc.

Nov 20, 2024

Nov 18, 2024

Research Analysts Issue Forecasts for ORIC FY2024 Earnings - Defense World

Nov 18, 2024

Nov 16, 2024

Oric Pharmaceuticals Inc (ORIC-Q) QuotePress Release - The Globe and Mail

Nov 16, 2024

Nov 16, 2024

Wedbush Lowers Earnings Estimates for ORIC Pharmaceuticals - Defense World

Nov 16, 2024

Nov 14, 2024

(ORIC) Trading Advice - Stock Traders Daily

Nov 14, 2024

Nov 14, 2024

ORIC Pharmaceuticals (NASDAQ:ORIC) Earns “Outperform” Rating from Wedbush - Defense World

Nov 14, 2024

Nov 13, 2024

Oric Pharmaceuticals Reports Strong Financial Growth and Clinical Progress - TipRanks

Nov 13, 2024

Nov 13, 2024

Alkeon Capital Management LLC's Strategic Acquisition in ORIC Ph - GuruFocus.com

Nov 13, 2024

Nov 13, 2024

Creative Planning Invests $116,000 in ORIC Pharmaceuticals, Inc. (NASDAQ:ORIC) - Defense World

Nov 13, 2024

Nov 13, 2024

FMR LLC Reduces Stake in ORIC Pharmaceuticals Inc - GuruFocus.com

Nov 13, 2024

Nov 12, 2024

ORIC Pharmaceuticals Inc Reports Q3 2024 Net Loss of $34.6 Milli - GuruFocus.com

Nov 12, 2024

Nov 12, 2024

ORIC Pharmaceuticals, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com

Nov 12, 2024

Nov 12, 2024

ORIC® Pharmaceuticals Reports Third Quarter 2024 Financial Results and Operational Updates - GlobeNewswire

Nov 12, 2024

Nov 12, 2024

ORIC Pharma Secures Major J&J, Bayer Partnerships; Reports $282M Cash Position | ORIC Stock News - StockTitan

Nov 12, 2024

Nov 08, 2024

ORIC Pharmaceuticals (NASDAQ:ORIC) Given “Buy” Rating at HC Wainwright - Defense World

Nov 08, 2024

Nov 06, 2024

ORICOric Pharmaceuticals, Inc. Latest Stock News & Market Updates - StockTitan

Nov 06, 2024

Nov 01, 2024

Wells Fargo Initiates Coverage of ORIC Pharmaceuticals (ORIC) with Overweight Recommendation - MSN

Nov 01, 2024

Nov 01, 2024

ORIC® Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - StockTitan

Nov 01, 2024

Nov 01, 2024

Brokerages Set ORIC Pharmaceuticals, Inc. (NASDAQ:ORIC) Price Target at $18.00 - Defense World

Nov 01, 2024

Oct 29, 2024

Dermavant acquisition expands Organon’s dermatology portfolio - Pharmaceutical Technology

Oct 29, 2024

Oct 23, 2024

ORIC-114 shows promise in preclinical cancer study By Investing.com - Investing.com Australia

Oct 23, 2024

Oct 23, 2024

ORIC-114 shows promise in preclinical cancer study - Investing.com

Oct 23, 2024

Oct 23, 2024

ORIC® Pharmaceuticals Presents Data Further Supporting Potential Best-In-Class Profile of ORIC-114 to Treat EGFR Exon 20 Insertions and Other Atypical Mutations at the EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics - GlobeNewswire

Oct 23, 2024